Tryp Therapeutics Inc.
TRYPF · OTC
8/31/2023 | 8/31/2022 | 8/31/2021 | 8/31/2020 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $345 | $1,796 | $3,692 | $1,019 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $29 | $6 | $22 | $0 |
| Inventory | $53 | $86 | $0 | $0 |
| Other Curr. Assets | $54 | $287 | $369 | $29 |
| Total Curr. Assets | $482 | $2,175 | $4,083 | $1,048 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $171 | $163 | $25 | $961 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $27 |
| Total NC Assets | $171 | $163 | $25 | $987 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $653 | $2,339 | $4,108 | $2,035 |
| Liabilities | – | – | – | – |
| Payables | $1,881 | $1,149 | $185 | $141 |
| Short-Term Debt | $0 | $0 | $0 | $5 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $90 | $46 | $0 | $47 |
| Total Curr. Liab. | $1,971 | $1,195 | $185 | $193 |
| LT Debt | $2,103 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $339 | $0 | $0 | $0 |
| Total NC Liab. | $2,442 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $4,413 | $1,195 | $185 | $193 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $13,497 | $13,497 | $9,692 | $2,265 |
| Retained Earnings | -$21,439 | -$16,172 | -$8,677 | -$423 |
| AOCI | $655 | $655 | $0 | $0 |
| Other Equity | $3,527 | $3,163 | $2,908 | $0 |
| Total Equity | -$3,760 | $1,143 | $3,923 | $1,842 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $653 | $2,339 | $4,108 | $2,035 |
| Net Debt | $1,758 | -$1,796 | -$3,692 | -$1,015 |